AstraZeneca is withdrawing its Covid-19 vaccine less than four years after its UK launch after a “surplus” of drugs targeting newer variants led to sinking demand for the jab.
On Wednesday AstraZeneca said it was “proud of the role Vaxzevria played in ending the global pandemic”, but was no longer manufacturing or supplying the drug due to a “surplus of available updated vaccines”.
The decision spells the end of the road for the drug that was created in collaboration with scientists from Oxford university within months of the outbreak of the pandemic, and approved in the UK in late 2020, with over 3bn doses supplied since its launch.
您已阅读23%（641字），剩余77%（2120字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。